Change in Number of Shares and Votes in Aerocrine
March 31 2015 - 2:08AM
Business Wire
Regulatory News:
Aerocrine (STO:AEROB)
With reference to Chapter 4 Section 9 in the Swedish Financial
Instruments Trading Act, it is hereby announced that through the
subscription by a new share issue related to the company’s stock
option program in Aerocrine AB (Nasdaq Stockholm: AERO), the number
of shares and votes in Aerocrine has increased during March 2015 as
specified in the table below.
Number of shares and votes March
1, 2015 698,137,454 Increase 629,598 March 31, 2015 698,766,052
About Aerocrine
Aerocrine AB is a medical products company focused on improved
management and care of patients with inflammatory airway diseases
such as Asthma. Within this sector, Aerocrine is the world leader.
Aerocrine markets NIOX MINO® and NIOX VERO®, which enables fast and
reliable point-of-care measurement of airway inflammation. These
products plays a critical role in more effective diagnosis,
treatment and follow-up of patients affected with inflammatory
airway diseases. Aerocrine is based in Sweden with subsidiaries in
the US, Germany, Switzerland and the UK. Aerocrine shares have
been listed on the Stockholm Stock Exchange since 2007 (AERO-B.ST).
For more information please visit www.aerocrine.com and
www.niox.com.
-----------------------------------------------------------------------------
Aerocrine is required to disclose the information provided
herein pursuant to| |the Financial Instruments Trading Act. The
information was submitted for publication at 08:00 am on March 31,
2015.
-----------------------------------------------------------------------------
This information was brought to you by Cision
http://news.cision.com
AerocrineMarshall Woodworth, CFO+1 919 749 8748+46 709
695 219